Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKAB2 | O43741 | 1/20 | 1.00 |
| ▸ | PRKAG1 | P54619 | 1/20 | 1.00 |
| ▸ | PRKAA2 | P54646 | 1/20 | 1.00 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 1.00 |
| ▸ | PRKAG3 | Q9UGI9 | 1/20 | 1.00 |
| ▸ | PRKAG2 | Q9UGJ0 | 1/20 | 1.00 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.48 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | NPY1R | P25929 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29611296 | 1.00 | PRKAB2 (1.00) | PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3 | |
| SCHEMBL19236034 | 1.00 | PRKAB2 (1.00) | PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3 | |
| SCHEMBL10001662 | 1.00 | PRKAB2 (1.00) | PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3 | |
| SCHEMBL19630453 | 0.93 | PRKAB2 (0.87) | PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3 | |
| SCHEMBL20880463 | 0.92 | PRKAB2 (0.85) | PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3 | |
| SCHEMBL10001663 | 0.92 | PRKAB2 (0.85) | PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3 | |
| SCHEMBL14922196 | 0.91 | PRKAB2 (0.83) | PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3 | |
| SCHEMBL20663726 | 0.90 | PRKAB2 (0.81) | PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3 | |
| SCHEMBL20663730 | 0.90 | PRKAB2 (0.81) | PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3 | |
| SCHEMBL19236026 | 0.84 | PRKAB2 (0.73) | PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112979734-B | Crystal form of triacetyl-3-hydroxy phenyl adenosine, preparation method and application thereof | 北京谷神生命健康科技有限公司 | 2024-01-02 | — | — | CN | claimed |
| EP-2407474-A1 | TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2012-01-18 | — | — | EP | claimed |
| CN-112979734-B | Crystal form of triacetyl-3-hydroxy phenyl adenosine, preparation method and application thereof | 北京谷神生命健康科技有限公司 | 2024-01-02 | — | — | CN | disclosed |
| CN-112979734-B | Crystal form of triacetyl-3-hydroxy phenyl adenosine, preparation method and application thereof | 北京谷神生命健康科技有限公司 | 2024-01-02 | — | — | CN | disclosed |
| WO-2017202297-A1 | APPLICATIONS OF TRIACETYL-3-HYDROXYL PHENYL ADENOSINE IN TREATING VASCULAR INFLAMMATIONS OR IMPROVING VASCULAR ENDOTHELIUM FUNCTIONS | 江苏天士力帝益药业有限公司 | 2017-11-30 | — | — | WO | disclosed |
| CN-104211747-A | Preparation and medical applications of 5'-phosphoric acid-N6-(3-hydroxylphenyl)adenosine | INST MATERIA MEDICA CAMS | 2014-12-17 | — | — | CN | disclosed |
| EP-2407474-B1 | TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT | INST MATERIA MEDICA CAMS (CN) | 2013-08-14 | — | — | EP | disclosed |
| US-8435962-B2 | Triacetyl-3-hydroxyphenyladenosine and its use for regulating blood fat | INSTITUTE OF MATARIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2013-05-07 | — | — | US | disclosed |
| US-8435962-B2 | Triacetyl-3-hydroxyphenyladenosine and its use for regulating blood fat | INSTITUTE OF MATARIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2013-05-07 | — | — | US | disclosed |
| US-20120053143-A1 | TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT | INSTITUTE OF MATARIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2012-03-01 | — | — | US | disclosed |
| US-20120053143-A1 | TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT | INSTITUTE OF MATARIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2012-03-01 | — | — | US | disclosed |
| CN-101874036-B | Triacetyl-3-hydroxyphenyl adenosine and its use in regulating blood fat | INST MATERIA MEDICA CAMS | 2012-01-25 | — | — | CN | disclosed |
| EP-2407474-A1 | TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2012-01-18 | — | — | EP | disclosed |
| EP-2407474-A1 | TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2012-01-18 | — | — | EP | disclosed |
| CN-101874036-A | Triacetyl-3-hydroxyphenyl adenosine and its use in regulating blood fat | INST OF MATARIA MEDICA CHINESE | 2010-10-27 | — | — | CN | disclosed |
| WO-2010040286-A1 | TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT | 中国医学科学院药物研究所 (CN) | 2010-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053143-A1 | TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT | ADORA3, ADORA2A, ADORA1 | PRKAB2 678/4885PRKAG1 496/4885PRKAA2 660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.